CF1 10.0% 2.2¢ complii fintech solutions ltd

I don't know how you've interpreted my post but let me clarify....

  1. 113 Posts.
    lightbulb Created with Sketch. 1
    I don't know how you've interpreted my post but let me clarify.

    What I'm saying relates to the post I quoted which discussed clients choosing not to sign binding agreements (as they don't want to be identified by name) and instead opting to just engage with IAM on a non-binding, per-usage basis.

    I'm saying that if this is the case, then management should provide the public with a regular guidance or forecast of throughput. This holds them accountable for performance, as it provides shareholders with some transparency to observe changes in demand, and with a better metric than simply just financials to judge if the company has performed above or below expectations.

    A comparable situation would be the expectation of a medical device company to provide annual and quarterly updates on unit sales forecasts, as well as previous quarter actuals vs. forecasts.
 
watchlist Created with Sketch. Add CF1 (ASX) to my watchlist
(20min delay)
Last
2.2¢
Change
0.002(10.0%)
Mkt cap ! $12.49M
Open High Low Value Volume
2.0¢ 2.2¢ 2.0¢ $36.83K 1.750M

Buyers (Bids)

No. Vol. Price($)
3 1662472 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 211200 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CF1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.